Reduced pain perception with Pen MateTM an automatic needle insertion device for use with an insulin pen
✍ Scribed by Diglas, J ;Feinböck, C ;Irsigler, K ;Winkler, F ;Egger, T ;Weitgasser, R ;Pieber, T ;Lytzen, L
- Book ID
- 104514816
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 378 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1357-8170
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The study examined glycaemic control and pain perception in patients using NovoPen® 3 with or without PenMate^TM^, an automatic injection device, in an open, cross‐over trial. Patients (n=57), who had been injecting insulin for at least 12 months and who had been using Novo Pen®3 for at least six weeks prior to the study, were randomised to use Novo Pen®3 with or without Pen Mate^TM^ for six weeks, before crossing over to the alternate system for a further six weeks. Pain perception was recorded night and morning on a 100mm visual analogue scale (VAS). Glycaemic control was monitored by HbA~1c~ measurements and by 4‐point blood glucose profiles. Pain perception was significantly lower with PenMate^TM^ (p=0.005). No statistical difference in HbA~1c~, blood glucose profiles or adverse events were found between the two systems. Patients found PenMate^TM^ easy to use and 84% said they would recommend the device to a person who is uncomfortable with needles.